December 1, 2010 --
San Diego -- Volcano Corporation (Nasdaq: VOLC), a
leading developer and manufacturer of precision intravascular
diagnosis and therapy guidance tools designed to enhance the
treatment of coronary and peripheral vascular disease, said
today that it will be participating in the 5th Annual Canaccord
Genuity Cardiovascular, Diabetes & Obesity Conference on Tuesday,
December 7.
|